LRP6 and breast cancer: LRP6 is an indispensable transmembrane receptor for Wnt and is overexpressed in several solid tumors, including colorectal [14], liver [15], and breast cancers [16], as well as pancreatic adenocarcinomas [17], in association with increased Wnt/β-catenin signaling.